References

Acierno MJ, Brown S, Coleman AE ACVIM consensus statement: guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med. 2018; 32:(6)1803-1822 https://doi.org/10.1111/jvim.15331

Al-Ghazlat SA, Langston CE, Greco DS The prevalence of microalbuminuria and proteinuria in cats with diabetes mellitus. Top Companion Anim Med. 2011; 26:(3)154-157 https://doi.org/10.1053/j.tcam.2011.04.005

Bijsmans ES, Jepson RE, Chang YM, Syme HM, Elliott J. Changes in systolic blood pressure over time in healthy cats and cats with chronic kidney disease. J Vet Intern Med. 2015; 29:(3)855-861 https://doi.org/10.1111/jvim.12600

Bijsmans ES, Doig M, Jepson RE Factors influencing the relationship between the dose of amlodipine required for blood pressure control and change in blood pressure in hypertensive cats. J Vet Intern Med. 2016; 30:(5)1630-1636 https://doi.org/10.1111/jvim.14562

Caney S. Feline blood pressure measurement: when is it needed?. Companion Animal. 2021; 26:(11)223-228 https://doi.org/10.12968/coan.2021.0063

Carter J. Hypertensive ocular disease in cats: A guide to fundic lesions to facilitate early diagnosis. 2018; 21:(1)35-45 https://doi.org/10.1177%2F1098612X18818668

Cole L, Jepson R, Humm K. Systemic hypertension in cats with acute kidney injury. J Small Anim Pract. 2017; 58:(10)577-581 https://doi.org/10.1111/jsap.12726

Coleman AE, Brown SA, Traas AM Safety and efficacy of orally administered telmisartan for the treatment of systemic hypertension in cats: results of a double-blind, placebo-controlled, randomized clinical trial. J Vet Intern Med. 2019; 33:(2)478-488 https://doi.org/10.1111/jvim.15429

Conroy M, Chang YM, Brodbelt D, Elliott J. Survival after diagnosis of hypertension in cats attending primary care practice in the United Kingdom. J Vet Intern Med. 2018; 32:(6)1846-1855 https://doi.org/10.1111/jvim.15307

Desmet L, van der Meer J. Antihypertensive treatment with telmisartan in a cat with amlodipine-induced gingival hyperplasia. JFMS Open Rep. 2017; 3:(2) https://doi.org/10.1177/2055116917745236

Elliott J, Barber PJ, Syme HM, Rawlings JM, Markwell PJ. Feline hypertension: clinical findings and response to antihypertensive treatment in 30 cases. J Small Anim Pract. 2001; 42:(3)122-129 https://doi.org/10.1111/j.1748-5827.2001.tb02008.x

Glaus TM, Elliott J, Herberich E, Zimmering T, Albrecht B. Efficacy of long-term oral telmisartan treatment in cats with hypertension: results of a prospective European clinical trial. J Vet Intern Med. 2019; 33:(2)413-422 https://doi.org/10.1111/jvim.15394

Henry CJ, Brewer WG, Montgomery RD Clinical vignette. Adrenal pheochromocytoma. J Vet Intern Med. 1993; 7:(3)199-201 https://doi.org/10.1111/j.1939-1676.1993.tb03188.x

Huh T, Larouche-Lebel É, Loughran KA, Oyama MA. Effect of angiotensin receptor blockers and angiotensin-converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in cats with heart disease. J Vet Intern Med. 2021; 35:(1)33-42 https://doi.org/10.1111/jvim.15948

Huhtinen M, Derré G, Renoldi HJ Randomized placebo-controlled clinical trial of a chewable formulation of amlodipine for the treatment of hypertension in client-owned cats. J Vet Intern Med. 2015; 29:(3)786-793 https://doi.org/10.1111/jvim.12589

Jenkins TL, Coleman AE, Schmiedt CW, Brown SA. Attenuation of the pressor response to exogenous angiotensin by angiotensin receptor blockers and benazepril hydrochloride in clinically normal cats. Am J Vet Res. 2015; 76:(9)807-813 https://doi.org/10.2460/ajvr.76.9.807

Jepson RE, Elliott J, Brodbelt D, Syme HM. Effect of control of systolic blood pressure on survival in cats with systemic hypertension. J Vet Intern Med. 2007; 21:(3)402-409 https://doi.org/10.1111/j.1939-1676.2007.tb02982.x

Kwiatkowska M, Hoppe S, Pomianowski A, Tipold A. Reactive seizures in cats: a retrospective study of 64 cases. Vet J. 2019; 244:1-6 https://doi.org/10.1016/j.tvjl.2018.11.009

Littman MP. Spontaneous systemic hypertension in 24 cats. J Vet Intern Med. 1994; 8:(2)79-86 https://doi.org/10.1111/j.1939-1676.1994.tb03202.x

Maggio F, DeFrancesco TC, Atkins CE Ocular lesions associated with systemic hypertension in cats: 69 cases (1985-1998). J Am Vet Med Assoc. 2000; 217:(5)695-702 https://doi.org/10.2460/javma.2000.217.695

Mathur S, Syme H, Brown CA Effects of the calcium channel antagonist amlodipine in cats with surgically induced hypertensive renal insufficiency. Am J Vet Res. 2002; 63:(6)833-839 https://doi.org/10.2460/ajvr.2002.63.833

Ni W, Yang X, Yang D Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. 2020; 24:(1) https://doi.org/10.1186/s13054-020-03120-0

Sansom J, Rogers K, Wood JL. Blood pressure assessment in healthy cats and cats with hypertensive retinopathy. Am J Vet Res. 2004; 65:(2)245-252 https://doi.org/10.2460/ajvr.2004.65.245

Sent U, Gossl R, Elliott J, Syme HM, Zimmering T. Comparison of efficacy of long-term oral treatment with telmisartan and benazepril in cats with chronic kidney disease. J Vet Intern Med. 2015; 29:(6)1479-1487 https://doi.org/10.1111/jvim.13639

Snyder PS, Sadek D, Jones GL. Effect of amlodipine on echocardiographic variables in cats with systemic hypertension. J Vet Intern Med. 2001; 15:(1)52-56 https://doi.org/10.1111/j.1939-1676.2001.tb02299.x

Syme HM, Markwell PJ, Pfeiffer D, Elliott J. Survival of cats with naturally occurring chronic renal failure is related to severity of proteinuria. J Vet Intern Med. 2006; 20:(3)528-535 https://doi.org/10.1111/j.1939-1676.2006.tb02892.x

Taylor SS, Sparkes AH, Briscoe K ISFM consensus guidelines on the diagnosis and management of hypertension in cats. J Feline Med Surg. 2017; 19:(3)288-303 https://doi.org/10.1177/1098612X17693500

Valentin SY, Cortright CC, Nelson RW Clinical findings, diagnostic test results, and treatment outcome in cats with spontaneous hyperadrenocorticism: 30 cases. J Vet Intern Med. 2014; 28:(2)481-487 https://doi.org/10.1111/jvim.12298

Secondary hypertension and its treatment in cats

02 June 2022
10 mins read
Volume 27 · Issue 6
Figure 2. Try and allow a cat time to acclimatise in the clinic before blood pressure measurement and keep them as relaxed as possible.
Figure 2. Try and allow a cat time to acclimatise in the clinic before blood pressure measurement and keep them as relaxed as possible.

Abstract

Secondary hypertension caused by an underlying disease is common in older cats, especially in those with chronic kidney disease and/or hyperthyroidism. Systolic blood pressure should be measured whenever an associated disease is diagnosed and persistent systolic blood pressure >160mmHg should prompt treatment to prevent or reverse target organ damage. Amlodipine and telmisartan are licensed in the UK to treat feline hypertension and both drugs have been evaluated in prospective randomised placebo-controlled clinical trials in hypertensive cats with systolic blood pressure of 160–200mmHg that did not have evidence of target organ damage. Initial reductions of 20–30mmHg can be expected with either medication, and cats should be re-evaluated after 14 days and dose adjustments made as required. No studies have compared the performance of one drug against the other and either medication should be selected as the first-line treatment for feline hypertension. At present, there are more data in the literature to support the use of amlodipine in cats with severe hypertension (systolic blood pressure >200mmHg), or with evidence of ocular or neurological target organ damage.

There are three types of hypertension, or high blood pressure, in cats: primary (idiopathic), secondary and situational (previously referred to as ‘white coat’ hypertension). Secondary hypertension, which develops in association with an underlying disease process or because of a medication or toxin, is the most common type of hypertension in cats (Taylor et al, 2017; Acierno et al, 2018). The conditions typically associated with hypertension occur with increasing prevalence in older cats; therefore, the prevalence of secondary hypertension also increases with advancing age (Bijsmans et al, 2015; Conroy et al, 2018). The most common cause of hypertension in cats is chronic kidney disease (Maggio et al, 2000; Elliott et al, 2001; Sansom et al, 2004; Conroy et al, 2018). Other conditions associated with high rates of hypertension include hyperthyroidism (Elliott et al, 2001; Conroy et al, 2018), acute kidney injury (Cole et al, 2017) and hyperaldosteronism (although this condition is uncommon). Pheochromocytoma and Cushing's syndrome (Henry et al, 1993; Valentin et al, 2014) can also cause hypertension, but both are rare in this species. Cats with diabetes mellitus can be documented to have concurrent hypertension, but it is not clear that it occurs with a higher frequency than in the general cat population (Al-Ghazlat et al, 2011). Documentation of any of these conditions should prompt blood pressure measurement; details on performing these measurements and when to do so are covered elsewhere (Caney, 2021).

Register now to continue reading

Thank you for visiting UK-VET Companion Animal and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.